Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.
Shimohama S, Tezuka T, Takahata K, Bun S, Tabuchi H, Seki M, Momota Y, Suzuki N, Morimoto A, Iwabuchi Y, Kubota M, Yamamoto Y, Sano Y, Shikimoto R, Funaki K, Mimura Y, Nishimoto Y, Ueda R, Jinzaki M, Nakahara J, Mimura M, Ito D. Shimohama S, et al. Among authors: morimoto a. Neurology. 2023 Jan 17;100(3):e264-e274. doi: 10.1212/WNL.0000000000201389. Epub 2022 Sep 29. Neurology. 2023. PMID: 36175151
Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies.
Tezuka T, Takahata K, Seki M, Tabuchi H, Momota Y, Shiraiwa M, Suzuki N, Morimoto A, Nakahara T, Iwabuchi Y, Miura E, Yamamoto Y, Sano Y, Funaki K, Yamagata B, Ueda R, Yoshizaki T, Mashima K, Shibata M, Oyama M, Okada K, Kubota M, Okita H, Takao M, Jinzaki M, Nakahara J, Mimura M, Ito D. Tezuka T, et al. Among authors: morimoto a. Brain Commun. 2021 Aug 24;3(4):fcab190. doi: 10.1093/braincomms/fcab190. eCollection 2021. Brain Commun. 2021. PMID: 34632382 Free PMC article.
Findings of 18 F-PI-2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sample.
Bun S, Moriguchi S, Tezuka T, Sato Y, Takahata K, Seki M, Nakajima S, Yamamoto Y, Sano Y, Suzuki N, Morimoto A, Ueda R, Tabuchi H, Ito D, Mimura M. Bun S, et al. Among authors: morimoto a. Neuropsychopharmacol Rep. 2022 Dec;42(4):437-448. doi: 10.1002/npr2.12281. Epub 2022 Jul 17. Neuropsychopharmacol Rep. 2022. PMID: 35843629 Free PMC article.
Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status.
Bun S, Ito D, Tezuka T, Kubota M, Ueda R, Takahata K, Moriguchi S, Kurose S, Momota Y, Suzuki N, Morimoto A, Hoshino Y, Seki M, Mimura Y, Shikimoto R, Yamamoto Y, Hoshino T, Sato Y, Tabuchi H, Mimura M. Bun S, et al. Among authors: morimoto a. Alzheimers Res Ther. 2023 Sep 4;15(1):149. doi: 10.1186/s13195-023-01296-5. Alzheimers Res Ther. 2023. PMID: 37667408 Free PMC article.
Clinical and laboratory findings characterizing the need for systemic corticosteroids and nonsteroidal systemic therapies, and the predicted outcomes in cutaneous polyarteritis nodosa: A single-centre retrospective analysis.
Tanaka R, Tanese K, Ito Y, Takeuchi S, Morimoto A, Sujino K, Amagai M, Tanikawa A. Tanaka R, et al. Among authors: morimoto a. Clin Exp Dermatol. 2024 May 9:llae143. doi: 10.1093/ced/llae143. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 38722089
696 results